A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix) today announces that the first patient in the United States (U.S ...

Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

The five-year relative survival for all cancers combined has reached a milestone, according to the American Cancer Society.

The NHS has expanded access to a prostate cancer drug across England in a move which could stop 8,000 former cancer patients from being told their illness has returned.

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What's more, the drug ...